Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model.

Autor: Budhu S; Swim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology, Weill Cornell Medical Center, New York, NY, United States., Kim K; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Yip W; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States., La Rosa S; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Jebiwott S; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Cai L; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Holland A; Swim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology, Weill Cornell Medical Center, New York, NY, United States., Thomas J; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Preise D; Department of Plants and Environmental Sciences, The Weizmann Institute of Science, Rehovot, Israel., Somma A; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Gordon B; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Scherz A; Department of Plants and Environmental Sciences, The Weizmann Institute of Science, Rehovot, Israel., Wolchok JD; Swim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology, Weill Cornell Medical Center, New York, NY, United States.; Department of Immunology, Weill Cornell Medical Center, New York, NY, United States.; Department of Medicine, Parker Institute for Cancer Immunotherapy and Sandra and Edward Meyer Cancer Center, Weill Cornell Medical Center, New York, NY, United States., Erinjeri J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Merghoub T; Swim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology, Weill Cornell Medical Center, New York, NY, United States.; Department of Medicine, Parker Institute for Cancer Immunotherapy and Sandra and Edward Meyer Cancer Center, Weill Cornell Medical Center, New York, NY, United States., Coleman JA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Jun 18; Vol. 14, pp. 1405486. Date of Electronic Publication: 2024 Jun 18 (Print Publication: 2024).

PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Autor: Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Medical College, Cornell University, New York, NY, USA., Galle PR; University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany., Chao Y; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan., Erinjeri J; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Medical College, Cornell University, New York, NY, USA., Heo J; Pusan National University, Busan, South Korea., Borad MJ; Gene and Virus Therapy Program, Mayo Clinic Cancer Center, Scottsdale, AZ, USA., Luca A; Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS-ISMETT), Palermo, Italy., Burke J; Sillajen Biotherapeutics, Inc., San Francisco, CA, USA., Pelusio A; Sillajen Biotherapeutics, Inc., San Francisco, CA, USA., Agathon D; Transgene S.A., Illkirch-Graffenstaden, France., Lusky M; Transgene S.A., Illkirch-Graffenstaden, France., Breitbach C; Sillajen Biotherapeutics, Inc., San Francisco, CA, USA., Qin S; Chinese People's Liberation Army Bayi Hospital, Nanjing, PR China., Gane E; New Zealand Liver Transplant Unit, Auckland City Hospital, University of Auckland, Auckland, New Zealand.

Publikováno v: Liver cancer [Liver Cancer] 2023 Sep 30; Vol. 13 (3), pp. 248-264. Date of Electronic Publication: 2023 Sep 30 (Print Publication: 2024).

Abstract No. 293 Quantifying the Learning Curve for Interventional Radiology Procedures

Autor: Erinjeri, J., Yarmohammadi, H., Zhan, C., Zhao, K., Ziv, E., Sofocleous, C., Solomon, S.

Publikováno v: In Journal of Vascular and Interventional Radiology March 2024 35(3) Supplement:S130-S130

Abstract No. 556 Genetic Alterations in Intrahepatic Cholangiocarcinoma and Response to Yttrium-90 Transarterial Radioembolization: A Case Series Exploring High Risk Genomics

Autor: Zhao, K., Ziv, E., Alexander, E., Sotirchos, V., Moussa, A., Marinelli, B., Erinjeri, J., Sofocleous, C., Harding, J., Sigel, C., Yarmohammadi, H.

Publikováno v: In Journal of Vascular and Interventional Radiology March 2023 34(3) Supplement:S155-S155

Abstract No. 157 Microwave Ablation of Colorectal Cancer Lung Metastases: Single-Center 10-Year Experience

Autor: Cooke, T., Sotirchos, V., Erinjeri, J., Petre, N., Sofocleous, C., Solomon, S.

Publikováno v: In Journal of Vascular and Interventional Radiology March 2023 34(3) Supplement:S73-S73